首页|血清γ-谷氨酰转肽酶水平与2型糖尿病患者心脑血管疾病风险的前瞻性队列研究

血清γ-谷氨酰转肽酶水平与2型糖尿病患者心脑血管疾病风险的前瞻性队列研究

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
目的 探讨江苏省2型糖尿病(T2DM)患者血清γ-谷氨酰转肽酶(GGT)水平与心脑血管疾病(CVD)及其亚型发病风险的关联.方法 研究对象来自江苏省社区糖尿病综合干预及应用研究,基线调查开展于2013-2014年,随访截至2021年12月31日.剔除基线自报患有慢性肝病/脑卒中/冠心病及GGT信息缺失者,最终纳入16 147名研究对象进行分析.采用Cox比例风险回归模型计算GGT与CVD、心肌梗死和脑卒中发病的风险比(HR)值及其95％CI.运用限制性立方样条模型分析GGT与CVD及其亚型发病风险的剂量反应关系.结果 研究对象中位随访时间为8.02年,随访期间共新发2860名CVD,其中新发196名心肌梗死,2730名脑卒中.多因素Cox比例风险回归模型结果显示,与GGT最低水平组相比,最高水平组的CVD和脑卒中发病风险分别增加24％(HR=1.24,95％CI:1.09～1.41)和23％(HR=1.23,95％CI:1.08～1.40).限制性立方样条模型结果显示,T2DM患者中GGT与CVD、心肌梗死和脑卒中呈非线性剂量反应关系.结论 较高水平的GGT可能与T2DM患者CVD发病风险升高相关,未来的临床实践中需要进一步探索验证.
Association of serum gamma-glutamyl transferase levels with cardiovascular disease risk in type 2 diabetes patients:a prospective cohort study
To investigate the associations of serum gamma-glutamyl transferase(GGT)levels with the risk of cardiovascular disease(CVD)and its subtypes in patients with type 2 diabetes mellitus(T2DM)in Jiangsu Province.Methods The participants were enrolled in the Comprehensive Research project regarding'Prevention and Control of Diabetes'in Jiangsu Province.The baseline survey was conducted from 2013 to 2014,and follow-up until December 31,2021.After excluding the participants who self-reported with chronic liver disease/stroke/coronary heart disease at baseline survey and those with incomplete information on GGT,a total of 16 147 T2DM patients were included in the final analysis.Cox proportional hazard regression models were used to calculate the hazard ratio(HR)and their 95％CI of GGT for CVD,myocardial infarction,and stroke.Restricted cubic spline models were applied to analyze the dose-response relationship between GGT and the risk of CVD and its subtypes.Results During the median follow-up time of 8.02 years,2860 CVD cases were registered,including 196 cases of myocardial infarction and 2 730 cases of stroke.Multivariate Cox proportional risk regression model indicated that compared to the lowest serum GGT level group,the highest GGT level group had a 24％increased risk of CVD(HR=1.24,95％CI:1.09-1.41)and a 23％increased risk of stroke(HR=1.23,95％CI:1.08-1.40).The restricted cubic spline model showed a nonlinear dose-response relationship between GGT and the risk of CVD,myocardial infarction,and stroke in T2DM patients.Conclusions High levels of GGT may be associated with an increased risk of cardiovascular disease in T2DM patients,which needs further exploration and validation in future clinical practice.

Diabetes mellitus,type 2Serum gamma-glutamyl transferaseCardiovascular diseaseProspective study

王勉、范习康、苏健、覃玉、沈冲、陆艳、孙中明、杨婕、陶然、周金意、武鸣

展开 >

南京医科大学公共卫生学院,南京 211166

江苏省疾病预防控制中心,南京 210009

苏州市疾病预防控制中心,苏州 215004

淮安市疾病预防控制中心,淮安 223001

展开 >

糖尿病,2型 血清γ-谷氨酰转肽酶 心脑血管疾病 前瞻性研究

江苏省医学领军人才和创新团队项目江苏省第五期"333工程"科研项目江苏省卫生健康委员会医学科研项目江苏省卫生健康委员会医学科研项目苏州市科技局民生科技-科技示范工程项目

K201105BRA2020090M2020085H2023022SS202010

2024

10.3760/cma.j.cn112338-20240628-00384

中华流行病学杂志
中华医学会

中华流行病学杂志

CSTPCD北大核心
影响因子：1.985
ISSN：0254-6450
年,卷(期)：2024.45(10)